Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drugEmilia Alors‐Pérez, Justo P. Castaño|Journal of Experimental & Clinical Cancer Research|2021Cited by 58
The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinomaRicardo Blázquez‐Encinas, Justo P. Castaño, Marina Sánchez‐Frías et al.|Cancer Gene Therapy|2024Cited by 6
Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drugEmilia Alors‐Pérez, Justo P. Castaño|Research Square|2021Cited by 2
The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in Pancreatic Ductal AdenocarcinomaRicardo Blázquez‐Encinas, Justo P. Castaño, Emilia Alors‐Pérez et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 0